Search
for
Sort by
Research 331–360 of 946
- Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- GREEN TEA EXTRACT IN AN EYELASH GROWTH ENHANCER GEL FORMULATION: STABILITY TEST, EYE IRRITATION TEST, AND HUMAN EYELASH GROWTH ACTIVITY
- The eyelash comes to the fore
- Eyelashes: Anatomical and Physiological Features, Eyelash Loss and Trichomegaly: Review
- Long-term safety and efficacy of Latisse (bimatoprost 0.03% solution) for treatment of eyelash hypotrichosis in subjects with chemotherapy induced and idiopathic hypotrichosis
- Bimatoprost in the treatment of eyelash hypotrichosis
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- Ocular Side Effects of Eyelash Extension Use Among Female Students of the University of Benin, Benin City, Edo State, Nigeria
- Isolated long white eyelash: An underrecognized trichologic finding
- Photo Quiz: Persistent eyelash debris in a 10-year-old female
- Correction of segmental vitiligo-associated eyelash leukotrichia using follicular unit extraction of dorsal toe hairs instead of scalp hairs
- Baricitinib Treatment Increases Eyebrow and Eyelash Regrowth Up to 52 Weeks
- 42146 Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- Keratosis follicularis spinulosa decalvans: a family study of seven male cases and six female carriers.
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Demodex
- Cetuximab-Associated Elongation of the Eyelashes
- Treatment of severe alopecia areata with baricitinib
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes
- The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows